Early Treatment of COVID-19 Disease: A Missed Opportunity

Antivirals have demonstrated efficacy in treating other infectious diseases in early stages of disease, reducing morbidity, mortality, and the likelihood of onward transmission. At the time of writing, more than 1900 clinical trials are registered globally to assess the efficacy and safety of candid...

Descripción completa

Detalles Bibliográficos
Autores principales: Forrest, Jamie I., Rayner, Craig R., Park, Jay J. H., Mills, Edward J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553378/
https://www.ncbi.nlm.nih.gov/pubmed/33051827
http://dx.doi.org/10.1007/s40121-020-00349-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553378/
https://www.ncbi.nlm.nih.gov/pubmed/33051827
http://dx.doi.org/10.1007/s40121-020-00349-8

Ejemplares similares